A Phase 1, Double-Blind (Sponsor Open), Randomized, Placebo- Controlled, Parallel Group, Oral Multiple-Dose Trial to Evaluate The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PF-03882845 in Healthy Volunteers.

Trial Profile

A Phase 1, Double-Blind (Sponsor Open), Randomized, Placebo- Controlled, Parallel Group, Oral Multiple-Dose Trial to Evaluate The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PF-03882845 in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Feb 2010

At a glance

  • Drugs PF 3882845 (Primary)
  • Indications Diabetic nephropathies
  • Focus Adverse reactions; Biomarker; Pharmacokinetics
  • Most Recent Events

    • 24 Feb 2010 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
    • 24 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Oct 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top